Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 44 | 2022 | 2176 | 6.080 |
Why?
|
| Alcohol Drinking | 27 | 2022 | 805 | 5.040 |
Why?
|
| Adolescent Behavior | 15 | 2020 | 264 | 3.380 |
Why?
|
| Cognition | 21 | 2022 | 513 | 3.100 |
Why?
|
| Adolescent Development | 14 | 2022 | 28 | 3.090 |
Why?
|
| Underage Drinking | 10 | 2020 | 25 | 3.000 |
Why?
|
| Marijuana Abuse | 14 | 2021 | 251 | 2.970 |
Why?
|
| Alcoholism | 15 | 2022 | 1109 | 2.730 |
Why?
|
| Substance-Related Disorders | 18 | 2022 | 1242 | 2.730 |
Why?
|
| Ethanol | 16 | 2022 | 893 | 2.530 |
Why?
|
| Adolescent | 74 | 2022 | 8912 | 2.450 |
Why?
|
| Marijuana Smoking | 12 | 2020 | 108 | 2.270 |
Why?
|
| Magnetic Resonance Imaging | 31 | 2021 | 2223 | 2.040 |
Why?
|
| Alcohol-Related Disorders | 6 | 2018 | 95 | 1.760 |
Why?
|
| Cannabis | 5 | 2021 | 115 | 1.550 |
Why?
|
| Cerebral Cortex | 11 | 2020 | 415 | 1.530 |
Why?
|
| Executive Function | 7 | 2021 | 106 | 1.490 |
Why?
|
| Binge Drinking | 6 | 2020 | 50 | 1.330 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2020 | 154 | 1.310 |
Why?
|
| Child | 39 | 2022 | 6405 | 1.290 |
Why?
|
| Memory, Short-Term | 5 | 2018 | 79 | 1.280 |
Why?
|
| Therapy, Computer-Assisted | 2 | 2019 | 57 | 1.240 |
Why?
|
| Avoidance Learning | 2 | 2019 | 58 | 1.240 |
Why?
|
| Humans | 93 | 2022 | 68618 | 1.160 |
Why?
|
| Neuropsychological Tests | 16 | 2020 | 517 | 1.100 |
Why?
|
| White Matter | 5 | 2015 | 174 | 1.090 |
Why?
|
| Acetylcysteine | 3 | 2019 | 296 | 1.060 |
Why?
|
| Male | 67 | 2022 | 37321 | 1.060 |
Why?
|
| Female | 65 | 2022 | 38074 | 1.030 |
Why?
|
| Child Development | 3 | 2021 | 102 | 1.020 |
Why?
|
| Young Adult | 28 | 2022 | 5717 | 0.940 |
Why?
|
| Cues | 7 | 2019 | 654 | 0.920 |
Why?
|
| Mental Disorders | 5 | 2021 | 659 | 0.900 |
Why?
|
| Psychomotor Performance | 7 | 2015 | 213 | 0.890 |
Why?
|
| Cannabidiol | 1 | 2021 | 31 | 0.780 |
Why?
|
| Smoking Cessation | 8 | 2022 | 1034 | 0.770 |
Why?
|
| Electronic Nicotine Delivery Systems | 2 | 2022 | 180 | 0.710 |
Why?
|
| Autism Spectrum Disorder | 1 | 2021 | 111 | 0.690 |
Why?
|
| Nerve Net | 3 | 2018 | 181 | 0.690 |
Why?
|
| Attention | 5 | 2020 | 225 | 0.690 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2019 | 29 | 0.690 |
Why?
|
| Memory | 5 | 2020 | 214 | 0.680 |
Why?
|
| Minority Groups | 1 | 2020 | 197 | 0.660 |
Why?
|
| Proof of Concept Study | 2 | 2018 | 38 | 0.660 |
Why?
|
| Prejudice | 1 | 2019 | 37 | 0.650 |
Why?
|
| Reward | 4 | 2020 | 201 | 0.650 |
Why?
|
| Patient Advocacy | 1 | 2019 | 40 | 0.650 |
Why?
|
| Racism | 1 | 2019 | 59 | 0.640 |
Why?
|
| Organ Size | 6 | 2021 | 242 | 0.630 |
Why?
|
| Medical Records | 1 | 2019 | 121 | 0.630 |
Why?
|
| Neuroimaging | 5 | 2021 | 122 | 0.620 |
Why?
|
| Longitudinal Studies | 13 | 2021 | 1054 | 0.620 |
Why?
|
| Students | 1 | 2020 | 233 | 0.620 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 109 | 0.610 |
Why?
|
| Tobacco Use Disorder | 2 | 2019 | 432 | 0.590 |
Why?
|
| Visual Perception | 3 | 2018 | 124 | 0.580 |
Why?
|
| Age Factors | 8 | 2019 | 1864 | 0.580 |
Why?
|
| Free Radical Scavengers | 2 | 2019 | 112 | 0.560 |
Why?
|
| Gray Matter | 5 | 2021 | 57 | 0.560 |
Why?
|
| Motivation | 3 | 2019 | 561 | 0.540 |
Why?
|
| Adult | 22 | 2022 | 21403 | 0.530 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 442 | 0.510 |
Why?
|
| Brain Mapping | 6 | 2019 | 532 | 0.510 |
Why?
|
| Physicians | 1 | 2019 | 324 | 0.500 |
Why?
|
| Receptors, Opioid, mu | 2 | 2014 | 70 | 0.500 |
Why?
|
| Pilot Projects | 6 | 2022 | 1342 | 0.480 |
Why?
|
| Tobacco Use | 4 | 2022 | 98 | 0.480 |
Why?
|
| Vaping | 3 | 2022 | 124 | 0.480 |
Why?
|
| Cognitive Dysfunction | 1 | 2017 | 176 | 0.470 |
Why?
|
| Psychology, Adolescent | 1 | 2014 | 38 | 0.470 |
Why?
|
| Oxygen | 3 | 2018 | 386 | 0.450 |
Why?
|
| Risk-Taking | 1 | 2015 | 210 | 0.440 |
Why?
|
| Marijuana Use | 3 | 2018 | 35 | 0.440 |
Why?
|
| Cross-Sectional Studies | 10 | 2021 | 2279 | 0.430 |
Why?
|
| Double-Blind Method | 7 | 2021 | 1738 | 0.410 |
Why?
|
| Family | 1 | 2014 | 293 | 0.400 |
Why?
|
| Risk Factors | 8 | 2021 | 5731 | 0.400 |
Why?
|
| Aging | 2 | 2015 | 911 | 0.390 |
Why?
|
| Varenicline | 3 | 2021 | 98 | 0.390 |
Why?
|
| Behavior, Addictive | 3 | 2019 | 317 | 0.380 |
Why?
|
| Follow-Up Studies | 12 | 2019 | 3259 | 0.370 |
Why?
|
| Narcotic Antagonists | 1 | 2012 | 184 | 0.360 |
Why?
|
| Memory Disorders | 1 | 2011 | 111 | 0.360 |
Why?
|
| Naltrexone | 1 | 2012 | 195 | 0.360 |
Why?
|
| Prospective Studies | 13 | 2021 | 3705 | 0.350 |
Why?
|
| Central Nervous System Depressants | 1 | 2011 | 182 | 0.340 |
Why?
|
| Socioeconomic Factors | 5 | 2021 | 955 | 0.340 |
Why?
|
| Sex Factors | 5 | 2016 | 1266 | 0.340 |
Why?
|
| Glutamic Acid | 2 | 2022 | 332 | 0.320 |
Why?
|
| Culture | 2 | 2019 | 75 | 0.290 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 179 | 0.290 |
Why?
|
| Psychopathology | 3 | 2021 | 29 | 0.280 |
Why?
|
| Machine Learning | 2 | 2019 | 170 | 0.270 |
Why?
|
| Treatment Outcome | 7 | 2019 | 7029 | 0.270 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2015 | 211 | 0.260 |
Why?
|
| Photic Stimulation | 2 | 2019 | 229 | 0.260 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 2 | 2022 | 27 | 0.250 |
Why?
|
| Pregnancy | 2 | 2020 | 2334 | 0.240 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2019 | 689 | 0.240 |
Why?
|
| Impulsive Behavior | 2 | 2020 | 85 | 0.210 |
Why?
|
| Choline | 1 | 2022 | 14 | 0.210 |
Why?
|
| Domestic Violence | 1 | 2022 | 36 | 0.200 |
Why?
|
| Gyrus Cinguli | 3 | 2021 | 113 | 0.200 |
Why?
|
| Parents | 2 | 2022 | 312 | 0.200 |
Why?
|
| Aspartic Acid | 1 | 2022 | 65 | 0.200 |
Why?
|
| Mass Media | 1 | 2021 | 29 | 0.200 |
Why?
|
| Cognition Disorders | 2 | 2015 | 342 | 0.200 |
Why?
|
| Emotions | 3 | 2018 | 244 | 0.200 |
Why?
|
| Case-Control Studies | 3 | 2020 | 1553 | 0.190 |
Why?
|
| Sexual and Gender Minorities | 1 | 2022 | 44 | 0.190 |
Why?
|
| Cyclonic Storms | 1 | 2021 | 59 | 0.190 |
Why?
|
| Craving | 3 | 2022 | 200 | 0.190 |
Why?
|
| Puberty | 1 | 2021 | 10 | 0.190 |
Why?
|
| Sexual Maturation | 1 | 2021 | 10 | 0.190 |
Why?
|
| United States | 5 | 2022 | 7367 | 0.190 |
Why?
|
| Cigarette Smoking | 2 | 2021 | 104 | 0.190 |
Why?
|
| Recreation | 1 | 2020 | 19 | 0.190 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 52 | 0.180 |
Why?
|
| Child Behavior | 1 | 2020 | 56 | 0.180 |
Why?
|
| Child of Impaired Parents | 1 | 2020 | 18 | 0.180 |
Why?
|
| Research Design | 2 | 2019 | 729 | 0.180 |
Why?
|
| Intention | 1 | 2021 | 80 | 0.180 |
Why?
|
| School Health Services | 1 | 2020 | 72 | 0.170 |
Why?
|
| Smoking | 2 | 2019 | 1452 | 0.170 |
Why?
|
| Neural Inhibition | 1 | 2020 | 80 | 0.170 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2021 | 208 | 0.170 |
Why?
|
| Schools | 1 | 2020 | 156 | 0.170 |
Why?
|
| Flavoring Agents | 1 | 2019 | 24 | 0.170 |
Why?
|
| Multimodal Imaging | 1 | 2019 | 62 | 0.170 |
Why?
|
| Verbal Learning | 2 | 2016 | 29 | 0.170 |
Why?
|
| False Negative Reactions | 1 | 2019 | 63 | 0.160 |
Why?
|
| Neural Pathways | 1 | 2021 | 324 | 0.160 |
Why?
|
| Bias | 1 | 2019 | 148 | 0.160 |
Why?
|
| Medication Adherence | 2 | 2019 | 335 | 0.160 |
Why?
|
| Bipolar Disorder | 1 | 2021 | 307 | 0.160 |
Why?
|
| Anxiety Disorders | 1 | 2021 | 426 | 0.160 |
Why?
|
| Affect | 3 | 2022 | 218 | 0.160 |
Why?
|
| Anxiety | 1 | 2021 | 422 | 0.160 |
Why?
|
| Prevalence | 2 | 2020 | 1619 | 0.160 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 240 | 0.160 |
Why?
|
| Child Health | 1 | 2018 | 15 | 0.160 |
Why?
|
| California | 1 | 2018 | 99 | 0.150 |
Why?
|
| Program Evaluation | 1 | 2020 | 502 | 0.150 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2020 | 782 | 0.150 |
Why?
|
| Wearable Electronic Devices | 1 | 2018 | 16 | 0.150 |
Why?
|
| Alcohol Abstinence | 2 | 2015 | 23 | 0.150 |
Why?
|
| Temperance | 1 | 2017 | 41 | 0.150 |
Why?
|
| Health Services Research | 1 | 2019 | 209 | 0.150 |
Why?
|
| Counseling | 1 | 2019 | 280 | 0.150 |
Why?
|
| Middle Aged | 8 | 2021 | 21147 | 0.140 |
Why?
|
| Prefrontal Cortex | 2 | 2020 | 640 | 0.140 |
Why?
|
| Cerebellum | 2 | 2020 | 103 | 0.140 |
Why?
|
| Social Media | 1 | 2018 | 59 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1745 | 0.140 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 951 | 0.140 |
Why?
|
| Behavior Therapy | 1 | 2019 | 297 | 0.140 |
Why?
|
| Internal-External Control | 1 | 2016 | 60 | 0.140 |
Why?
|
| Sleep Wake Disorders | 1 | 2017 | 94 | 0.130 |
Why?
|
| Frontal Lobe | 2 | 2015 | 156 | 0.130 |
Why?
|
| Breath Tests | 2 | 2015 | 23 | 0.130 |
Why?
|
| Social Environment | 1 | 2016 | 182 | 0.130 |
Why?
|
| Corpus Callosum | 1 | 2015 | 29 | 0.130 |
Why?
|
| Neocortex | 1 | 2015 | 17 | 0.130 |
Why?
|
| Pons | 1 | 2015 | 35 | 0.130 |
Why?
|
| Sleep | 1 | 2017 | 263 | 0.120 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 1465 | 0.120 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 581 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 931 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 767 | 0.120 |
Why?
|
| Functional Neuroimaging | 3 | 2021 | 82 | 0.120 |
Why?
|
| Telemedicine | 1 | 2022 | 700 | 0.110 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 49 | 0.110 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2014 | 82 | 0.110 |
Why?
|
| Temporal Lobe | 1 | 2014 | 125 | 0.110 |
Why?
|
| Amnesia, Retrograde | 1 | 2012 | 2 | 0.110 |
Why?
|
| Drinking Behavior | 1 | 2012 | 20 | 0.110 |
Why?
|
| Depression | 1 | 2019 | 943 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2014 | 627 | 0.100 |
Why?
|
| Disulfiram | 1 | 2012 | 22 | 0.100 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2012 | 51 | 0.100 |
Why?
|
| Taurine | 1 | 2012 | 51 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2012 | 144 | 0.100 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2021 | 1506 | 0.090 |
Why?
|
| Alleles | 1 | 2012 | 386 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2012 | 111 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2016 | 824 | 0.090 |
Why?
|
| Animals | 2 | 2020 | 20881 | 0.090 |
Why?
|
| Spatial Behavior | 1 | 2009 | 18 | 0.080 |
Why?
|
| Aged | 4 | 2018 | 14862 | 0.080 |
Why?
|
| Language | 1 | 2009 | 120 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2009 | 737 | 0.070 |
Why?
|
| Parietal Lobe | 2 | 2020 | 59 | 0.070 |
Why?
|
| Analysis of Variance | 3 | 2015 | 1040 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 2550 | 0.070 |
Why?
|
| Self Report | 2 | 2021 | 371 | 0.070 |
Why?
|
| Rats | 1 | 2014 | 5300 | 0.070 |
Why?
|
| Recurrence | 1 | 2009 | 948 | 0.070 |
Why?
|
| Comorbidity | 2 | 2019 | 1426 | 0.060 |
Why?
|
| Tobacco Products | 2 | 2018 | 234 | 0.060 |
Why?
|
| Surveys and Questionnaires | 3 | 2018 | 2800 | 0.060 |
Why?
|
| Reaction Time | 2 | 2018 | 170 | 0.060 |
Why?
|
| Time Factors | 3 | 2017 | 4655 | 0.050 |
Why?
|
| Sexism | 1 | 2022 | 11 | 0.050 |
Why?
|
| Sexuality | 1 | 2022 | 12 | 0.050 |
Why?
|
| Peer Review | 1 | 2022 | 16 | 0.050 |
Why?
|
| Parent-Child Relations | 1 | 2022 | 98 | 0.050 |
Why?
|
| Florida | 1 | 2021 | 221 | 0.050 |
Why?
|
| Dehydroepiandrosterone | 1 | 2021 | 29 | 0.050 |
Why?
|
| Hobbies | 1 | 2020 | 4 | 0.050 |
Why?
|
| Incidental Findings | 1 | 2021 | 42 | 0.050 |
Why?
|
| Sexual Behavior | 1 | 2022 | 183 | 0.050 |
Why?
|
| Testosterone | 1 | 2021 | 96 | 0.050 |
Why?
|
| Sports | 1 | 2020 | 55 | 0.040 |
Why?
|
| Reference Values | 1 | 2021 | 579 | 0.040 |
Why?
|
| Amygdala | 1 | 2021 | 159 | 0.040 |
Why?
|
| Estradiol | 1 | 2021 | 176 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2022 | 652 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2021 | 307 | 0.040 |
Why?
|
| Hallucinogens | 1 | 2019 | 14 | 0.040 |
Why?
|
| Mindfulness | 1 | 2019 | 41 | 0.040 |
Why?
|
| Dronabinol | 1 | 2019 | 84 | 0.040 |
Why?
|
| Drug Substitution | 1 | 2018 | 19 | 0.040 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2019 | 100 | 0.040 |
Why?
|
| Individuality | 1 | 2018 | 44 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2021 | 383 | 0.040 |
Why?
|
| Family Therapy | 1 | 2019 | 82 | 0.040 |
Why?
|
| Hippocampus | 1 | 2021 | 471 | 0.040 |
Why?
|
| Southeastern United States | 1 | 2018 | 281 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2019 | 183 | 0.040 |
Why?
|
| Substance Abuse Detection | 1 | 2017 | 66 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 239 | 0.040 |
Why?
|
| Ecological Momentary Assessment | 1 | 2016 | 16 | 0.040 |
Why?
|
| Cannabinoids | 1 | 2017 | 90 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2018 | 296 | 0.030 |
Why?
|
| Risk | 1 | 2018 | 563 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2018 | 237 | 0.030 |
Why?
|
| Tobacco Smoking | 1 | 2016 | 41 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2018 | 295 | 0.030 |
Why?
|
| Decision Making | 1 | 2019 | 410 | 0.030 |
Why?
|
| Urinalysis | 1 | 2015 | 27 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 2358 | 0.030 |
Why?
|
| Patient Selection | 1 | 2019 | 592 | 0.030 |
Why?
|
| Age of Onset | 1 | 2015 | 188 | 0.030 |
Why?
|
| Anisotropy | 1 | 2015 | 105 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 786 | 0.030 |
Why?
|
| Smokers | 1 | 2016 | 200 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 1603 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 3187 | 0.030 |
Why?
|
| Minisatellite Repeats | 1 | 2014 | 16 | 0.030 |
Why?
|
| Gene-Environment Interaction | 1 | 2014 | 31 | 0.030 |
Why?
|
| South Carolina | 1 | 2020 | 2752 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 2077 | 0.030 |
Why?
|
| Arousal | 1 | 2014 | 168 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2014 | 249 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 334 | 0.030 |
Why?
|
| Mental Health | 1 | 2015 | 278 | 0.030 |
Why?
|
| Health Status | 1 | 2015 | 429 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2015 | 506 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 786 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 7277 | 0.020 |
Why?
|